Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels

Not Applicable

Recruiting

• Conditions: NAD+ Levels in the Blood

• Registration Number: NCT06505967
• Lead Sponsor: Qualia Life Sciences

Brief Summary

The goal of this clinical trial is to determine if Qualia NAD+ effectively increases NAD+ levels in the blood and to evaluate its safety.

Researchers will compare Qualia NAD+ to a placebo (a look-alike substance that contains no active drug) to assess its efficacy in increasing NAD+ levels in the blood.

Participants will:

Take Qualia NAD+ or a placebo every day for 4 weeks. Undergo blood tests before and after the trial.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-10
• Status Verified: 2024-07
• Study First Submitted: 2024-07-11
• Study First Submitted QC: 2024-07-11
• Last Update Submitted: 2024-07-11
• Study First Posted: 2024-07-17
• Last Update Posted: 2024-07-17
• Primary Completion: 2024-08-18
• Study Completion: 2024-09-09

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
NAD+ Levels in the Blood	4 weeks

Trial Locations

Locations (1)

Qualia Life Sciences; 🇺🇸 Carlsbad, California, United States